ACTA1 and cancer: Several studies in multiple cancer types, including PDAC, have shown correlations between the number of α-SMA+ CAF and poor clinical outcomes [115,116,117,118]; however in a murine model when α-SMA-expressing cells were genetically depleted in pancreatic cancer, poorly differentiated tumors and shortened survival time were observed.